TRIP13 and plasma cell myeloma: In addition, CD138+ cells from four patients with relapsed refractory myeloma and PBMCs from four healthy donors were collected, and the protein levels of TRIP13, YWHAE, and p-ERK were determined by performing immunoblotting.